Wolfram Ruf1. 1. Department of Immunology, The Scripps Research Institute, La Jolla, CA, USA.
Abstract
OBJECTIVE: To discuss recent studies addressing the relationship between protease-activated receptor signaling, coagulation, and inflammation. DATA EXTRACTION AND SYNTHESIS: This review article covers relevant original articles published until October 2003 dealing with animal models, clinical trial data, and in vitro experiments. CONCLUSIONS: Although activation of protease-activated receptors has been implicated in the proinflammatory effects of the coagulation cascade, current data provide evidence that protease-activated receptor signaling plays a more complex role in the regulation of inflammation and endothelial homeostasis. Sensitive assays for coagulation activation have provided clear evidence that targeting the coagulation pathway effectively reduces the coagulopathy in sepsis. However, the effect of these anticoagulant agents on sepsis-associated inflammation is less clear. Further insight into this question will require the development or use of additional biomarkers for assessing pharmacologic interference with coagulation-related cell-signaling pathways.
OBJECTIVE: To discuss recent studies addressing the relationship between protease-activated receptor signaling, coagulation, and inflammation. DATA EXTRACTION AND SYNTHESIS: This review article covers relevant original articles published until October 2003 dealing with animal models, clinical trial data, and in vitro experiments. CONCLUSIONS: Although activation of protease-activated receptors has been implicated in the proinflammatory effects of the coagulation cascade, current data provide evidence that protease-activated receptor signaling plays a more complex role in the regulation of inflammation and endothelial homeostasis. Sensitive assays for coagulation activation have provided clear evidence that targeting the coagulation pathway effectively reduces the coagulopathy in sepsis. However, the effect of these anticoagulant agents on sepsis-associated inflammation is less clear. Further insight into this question will require the development or use of additional biomarkers for assessing pharmacologic interference with coagulation-related cell-signaling pathways.
Authors: John Hallenbeck; Gregory Del Zoppo; Tom Jacobs; Antoine Hakim; Stephen Goldman; Ursula Utz; Ahmed Hasan Journal: Stroke Date: 2006-11-02 Impact factor: 7.914
Authors: Eric Camerer; Ivo Cornelissen; Hiroshi Kataoka; Daniel N Duong; Yao-Wu Zheng; Shaun R Coughlin Journal: Blood Date: 2006-01-24 Impact factor: 22.113
Authors: Eric Calvo; Daniella M Mizurini; Anderson Sá-Nunes; José M C Ribeiro; John F Andersen; Ben J Mans; Robson Q Monteiro; Michail Kotsyfakis; Ivo M B Francischetti Journal: J Biol Chem Date: 2011-06-14 Impact factor: 5.157
Authors: Sohel M Julovi; Meilang Xue; Suat Dervish; Philip N Sambrook; Lyn March; Christopher John Jackson Journal: Am J Pathol Date: 2011-09-09 Impact factor: 4.307
Authors: Sohel M Julovi; Kaitlin Shen; Kelly Mckelvey; Nikita Minhas; Lyn March; Christopher J Jackson Journal: Mol Med Date: 2013-10-24 Impact factor: 6.354
Authors: Ivo M B Francischetti; Van My Pham; Ben J Mans; John F Andersen; Thomas N Mather; Robert S Lane; José M C Ribeiro Journal: Insect Biochem Mol Biol Date: 2005-10 Impact factor: 4.714
Authors: Melissa E Schechter; Bruno B Andrade; Tianyu He; George Haret Richter; Kevin W Tosh; Benjamin B Policicchio; Amrit Singh; Kevin D Raehtz; Virginia Sheikh; Dongying Ma; Egidio Brocca-Cofano; Cristian Apetrei; Russel Tracy; Ruy M Ribeiro; Alan Sher; Ivo M B Francischetti; Ivona Pandrea; Irini Sereti Journal: Sci Transl Med Date: 2017-08-30 Impact factor: 17.956
Authors: Bi-Sen Ding; Nankang Hong; Melpo Christofidou-Solomidou; Claudia Gottstein; Steven M Albelda; Douglas B Cines; Aron B Fisher; Vladimir R Muzykantov Journal: Am J Respir Crit Care Med Date: 2009-04-02 Impact factor: 21.405